Equity Research, Broker Reports, and media content on APONTIS PHARMA AG

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about APONTIS PHARMA AG
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

APONTIS PHARMA AG

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on APONTIS PHARMA AG. We currently have 3 research reports from 1 professional analysts.

Date Source Announcement
19Jul22 06:30 EQS-News DGAP-News: APONTIS PHARMA und Midas Pharma vereinbaren weitere Entwicklungspartnerschaft zur Markteinführung einer Single Pill mit europaweiten Schutzrechten
19Jul22 06:30 EQS-News DGAP-News: APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan-European intellectual property rights
06Jul22 06:30 EQS-News DGAP-News: APONTIS PHARMA führt eine neue Single Pill zur Sekundärprophylaxe in den Markt ein
06Jul22 06:30 EQS-News DGAP-News: APONTIS PHARMA rolls out new Single Pill for secondary prophylaxis
23Jun22 06:30 EQS-News DGAP-News: APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
23Jun22 06:30 EQS-News DGAP-News: APONTIS PHARMA AG: Bekanntmachung gemäß Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052
25May22 06:30 EQS-News DGAP-News: APONTIS PHARMA führt zwei neue Single Pills in den Markt ein – mittelfristiges Umsatzpotenzial von EUR 8,2 Mio.
  • Frequency of research reports

     

  • Research reports on

    APONTIS PHARMA AG

  • Providers covering

    APONTIS PHARMA AG